- Home
- FRGT vs GRI Comparison
FRGT vs GRI Comparison
Compare FRGT & GRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGT
- GRI
- Stock Information
- Founded
- FRGT 2015
- GRI 2018
- Country
- FRGT Mexico
- GRI United States
- Employees
- FRGT N/A
- GRI N/A
- Industry
- FRGT Professional Services
- GRI Biotechnology: Pharmaceutical Preparations
- Sector
- FRGT Consumer Discretionary
- GRI Health Care
- Exchange
- FRGT Nasdaq
- GRI Nasdaq
- Market Cap
- FRGT 3.5M
- GRI 3.6M
- IPO Year
- FRGT N/A
- GRI N/A
- Fundamental
- Price
- FRGT $1.41
- GRI $1.81
- Analyst Decision
- FRGT
- GRI Strong Buy
- Analyst Count
- FRGT 0
- GRI 2
- Target Price
- FRGT N/A
- GRI $22.00
- AVG Volume (30 Days)
- FRGT 160.2K
- GRI 3.2M
- Earning Date
- FRGT 08-18-2025
- GRI 08-14-2025
- Dividend Yield
- FRGT N/A
- GRI N/A
- EPS Growth
- FRGT N/A
- GRI N/A
- EPS
- FRGT N/A
- GRI N/A
- Revenue
- FRGT $12,693,870.00
- GRI N/A
- Revenue This Year
- FRGT $371.03
- GRI N/A
- Revenue Next Year
- FRGT N/A
- GRI N/A
- P/E Ratio
- FRGT N/A
- GRI N/A
- Revenue Growth
- FRGT N/A
- GRI N/A
- 52 Week Low
- FRGT $1.15
- GRI $1.10
- 52 Week High
- FRGT $16.70
- GRI $30.43
- Technical
- Relative Strength Index (RSI)
- FRGT 51.20
- GRI 59.98
- Support Level
- FRGT $1.17
- GRI $1.47
- Resistance Level
- FRGT $1.50
- GRI $2.87
- Average True Range (ATR)
- FRGT 0.12
- GRI 0.20
- MACD
- FRGT 0.04
- GRI 0.06
- Stochastic Oscillator
- FRGT 74.29
- GRI 31.17
About FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.